Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viridian Therapeutics Inc
(NQ:
VRDN
)
14.47
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viridian Therapeutics Inc
< Previous
1
2
3
4
5
Next >
JetBlue Airways, VOXX International And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
July 11, 2023
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)
July 10, 2023
From
Viridian Therapeutics, Inc.
Via
Business Wire
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
July 06, 2023
From
Viridian Therapeutics, Inc.
Via
Business Wire
11 Analysts Have This to Say About Viridian Therapeutics
June 14, 2023
Via
Benzinga
Analyst Ratings for Viridian Therapeutics
May 10, 2023
Via
Benzinga
Recap: Viridian Therapeutics Q1 Earnings
May 09, 2023
Via
Benzinga
Earnings Outlook For Viridian Therapeutics
May 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
June 14, 2023
Via
Benzinga
Viridian Therapeutics Announces Presentations at the 2023 Annual Meeting of the Endocrine Society
June 13, 2023
From
Viridian Therapeutics, Inc.
Via
Business Wire
Expert Ratings for Viridian Therapeutics
April 17, 2023
Via
Benzinga
Analyst Expectations for Viridian Therapeutics's Future
March 30, 2023
Via
Benzinga
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2023
From
Viridian Therapeutics, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023
May 30, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
March 30, 2023
Via
Benzinga
Viridian Therapeutics Earnings Perspective: Return On Capital Employed
March 10, 2023
Via
Benzinga
Earnings Scheduled For May 9, 2023
May 09, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
Via
Benzinga
Analyst Expectations for Viridian Therapeutics's Future
March 09, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
December 19, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
April 17, 2023
Via
Benzinga
Viridian Therapeutics' Lead Product Has An Opportunity To Differentiate, Analyst Sees 85% Upside
December 16, 2022
Via
Benzinga
Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday
November 30, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Earnings Scheduled For March 8, 2023
March 08, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Via
Benzinga
Viridian Therapeutics Earnings Preview
March 07, 2023
Via
Benzinga
The Latest Analyst Ratings for Viridian Therapeutics
February 07, 2023
Via
Benzinga
Viridian's Thyroid Eye Disease Candidate Shows Promise At Lower Doses
January 09, 2023
Via
Benzinga
Viridian Therapeutics Earnings Perspective: Return On Capital Employed
December 23, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
December 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 30, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via
Benzinga
Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session
November 30, 2022
Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.